Chemistry:Fadrozole

From HandWiki
Revision as of 09:40, 6 March 2023 by MedAI (talk | contribs) (add)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
Fadrozole
Fadrozole structure.svg
Clinical data
Trade namesAfema
Routes of
administration
By mouth
Drug classAromatase inhibitor; Antiestrogen
ATC code
  • None
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC14H13N3
Molar mass223.279 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Fadrozole (INN), sold under the brand name Afema (by Novartis), is a selective, nonsteroidal aromatase inhibitor which is or has been used in Japan for the treatment of breast cancer.[1][2]


References

  1. "Fadrozole hydrochloride: a potent, selective, nonsteroidal inhibitor of aromatase for the treatment of estrogen-dependent disease". J. Med. Chem. 34 (2): 725–36. February 1991. doi:10.1021/jm00106a038. PMID 1825337. 
  2. "A study of fadrozole, a new aromatase inhibitor, in postmenopausal women with advanced metastatic breast cancer". J. Clin. Oncol. 10 (1): 111–6. January 1992. doi:10.1200/jco.1992.10.1.111. PMID 1530798. http://www.jco.org/cgi/pmidlookup?view=long&pmid=1530798.